Published in J Cyst Fibros on May 03, 2007
Caregiver perspectives on discussions about the use of intensive treatments in cystic fibrosis. J Pain Symptom Manage (2010) 0.81
End-of-Life Care Patterns Associated with Pediatric Palliative Care among Children Who Underwent Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant (2016) 0.80
End-of-life care in a COPD patient awaiting lung transplantation: a case report. BMC Palliat Care (2010) 0.75
Family perspectives on end-of-life care at the last place of care. JAMA (2004) 10.13
Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med (2000) 7.20
Symptoms and suffering at the end of life in children with cancer. N Engl J Med (2000) 6.75
Prediction of mortality in patients with cystic fibrosis. N Engl J Med (1992) 5.46
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
Place of death: preferences among cancer patients and their carers. Soc Sci Med (2004) 2.87
Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med (2005) 2.29
Trends in the place of death of cancer patients, 1992-1997. CMAJ (2003) 2.18
Outcomes of intensive care unit care in adults with cystic fibrosis. Am J Respir Crit Care Med (2001) 1.68
End-of-life care in cystic fibrosis. Pediatrics (1997) 1.55
Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med (2001) 1.52
The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report--2004. J Heart Lung Transplant (2004) 1.28
End-of-life care in acute care hospitals in Canada: a quality finish? J Palliat Care (2005) 1.22
One-year outcome after severe pulmonary exacerbation in adults with cystic fibrosis. Am J Respir Crit Care Med (2004) 1.22
Associations between clinical variables and quality of life in adults with cystic fibrosis. J Cyst Fibros (2005) 1.20
Assisted ventilation for patients with cystic fibrosis. JAMA (1978) 1.20
Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects. Eur Respir J (1997) 1.19
Measuring the quality of life before and after bilateral lung transplantation in patients with cystic fibrosis. Chest (1994) 1.09
Oregon's low in-hospital death rates: what determines where people die and satisfaction with decisions on place of death? Ann Intern Med (1999) 1.04
Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis. Pediatr Pulmonol (2006) 1.04
Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis. J Clin Nurs (2006) 1.01
Long-term noninvasive mechanical ventilation for children at home: a national survey. Pediatr Pulmonol (2003) 1.00
Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis. Pediatr Pulmonol (1997) 0.98
Long term results of lung transplantation for cystic fibrosis. Eur J Cardiothorac Surg (2002) 0.98
Invasive mechanical ventilation for acute respiratory failure in children with cystic fibrosis: outcome analysis and case-control study. Pediatr Pulmonol (2002) 0.97
Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure. Eur Respir J (2002) 0.96
Burkholderia cepacia is associated with pulmonary hypertension and increased mortality among cystic fibrosis patients. J Clin Microbiol (2004) 0.95
The evolution of palliative care. J R Soc Med (2001) 0.86
Cystic fibrosis. End-stage care in Canada. Chest (2000) 0.86
End of life care for adult cystic fibrosis patients: facilitating a good enough death. J Cyst Fibros (2005) 0.81
Improving end-of-life care: gathering suggestions from family members. Nurs Forum (2000) 0.81
Use of bilevel positive airway pressure (BIPAP) in end-stage patients with cystic fibrosis awaiting lung transplantation. Clin Pediatr (Phila) (1998) 0.81
Noninvasive ventilation in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis. Eur Respir J (2002) 0.77
The "STATE" of home care and hospice. Caring (2006) 0.76
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest (2002) 6.35
An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med (2011) 5.53
Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med (2005) 5.51
Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell (2002) 4.94
Well-differentiated human airway epithelial cell cultures. Methods Mol Med (2005) 4.66
Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med (2003) 4.33
Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia. Circulation (2007) 4.17
An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med (2008) 3.98
Mutations of DNAH11 in patients with primary ciliary dyskinesia with normal ciliary ultrastructure. Thorax (2011) 2.80
Deletions and point mutations of LRRC50 cause primary ciliary dyskinesia due to dynein arm defects. Am J Hum Genet (2009) 2.10
Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease. Am J Respir Crit Care Med (2013) 2.09
Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis. Am J Respir Crit Care Med (2002) 1.94
Zebrafish Ciliopathy Screen Plus Human Mutational Analysis Identifies C21orf59 and CCDC65 Defects as Causing Primary Ciliary Dyskinesia. Am J Hum Genet (2013) 1.90
Mutations of DNAI1 in primary ciliary dyskinesia: evidence of founder effect in a common mutation. Am J Respir Crit Care Med (2006) 1.80
A bacterial cell to cell signal in the lungs of cystic fibrosis patients. FEMS Microbiol Lett (2002) 1.72
Physiologic, bronchoscopic, and bronchoalveolar lavage fluid findings in young children with recurrent wheeze and cough. Pediatr Pulmonol (2006) 1.65
Exome sequencing identifies mutations in CCDC114 as a cause of primary ciliary dyskinesia. Am J Hum Genet (2012) 1.65
Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data. Am J Respir Crit Care Med (2006) 1.63
Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med (2007) 1.55
Whole-exome capture and sequencing identifies HEATR2 mutation as a cause of primary ciliary dyskinesia. Am J Hum Genet (2012) 1.53
Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines. J Pediatr (2007) 1.45
DYX1C1 is required for axonemal dynein assembly and ciliary motility. Nat Genet (2013) 1.44
Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatr Pulmonol (2005) 1.42
Next generation massively parallel sequencing of targeted exomes to identify genetic mutations in primary ciliary dyskinesia: implications for application to clinical testing. Genet Med (2011) 1.42
Mutations in CCDC39 and CCDC40 are the major cause of primary ciliary dyskinesia with axonemal disorganization and absent inner dynein arms. Hum Mutat (2013) 1.31
Reduced expression of IRF7 in nasal epithelial cells from smokers after infection with influenza. Am J Respir Cell Mol Biol (2009) 1.29
High-resolution CT of patients with primary ciliary dyskinesia. AJR Am J Roentgenol (2007) 1.26
Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure. J Clin Invest (2014) 1.26
ZMYND10 is mutated in primary ciliary dyskinesia and interacts with LRRC6. Am J Hum Genet (2013) 1.24
Bronchoalveolar lavage fluid surfactant protein-A and surfactant protein-D are inversely related to inflammation in early cystic fibrosis. Am J Respir Crit Care Med (2003) 1.22
Diagnostic yield of nasal scrape biopsies in primary ciliary dyskinesia: a multicenter experience. Pediatr Pulmonol (2011) 1.22
Mutations in SPAG1 cause primary ciliary dyskinesia associated with defective outer and inner dynein arms. Am J Hum Genet (2013) 1.19
ARMC4 mutations cause primary ciliary dyskinesia with randomization of left/right body asymmetry. Am J Hum Genet (2013) 1.17
Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity (Silver Spring) (2013) 1.17
Mutations in RSPH1 cause primary ciliary dyskinesia with a unique clinical and ciliary phenotype. Am J Respir Crit Care Med (2014) 1.14
Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotype. Am J Respir Crit Care Med (2015) 1.09
Early lung disease in young children with primary ciliary dyskinesia. Pediatr Pulmonol (2008) 1.08
Association of lower airway inflammation with physiologic findings in young children with cystic fibrosis. Pediatr Pulmonol (2009) 1.06
Investigation of the possible role of a novel gene, DPCD, in primary ciliary dyskinesia. Am J Respir Cell Mol Biol (2003) 1.05
Nasal lavage natural killer cell function is suppressed in smokers after live attenuated influenza virus. Respir Res (2011) 1.04
Ciliopathies: the central role of cilia in a spectrum of pediatric disorders. J Pediatr (2011) 1.03
Burkholderia gladioli: five year experience in a cystic fibrosis and lung transplantation center. J Cyst Fibros (2006) 1.01
Quantitative cytokine gene expression in CF airway. Pediatr Pulmonol (2004) 1.01
The effect of respiratory synctial virus on chemokine release by differentiated airway epithelium. Exp Lung Res (2004) 1.00
Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy. Pediatr Pulmonol (2011) 0.98
Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation. EMBO Rep (2004) 0.98
Are lower airway or throat cultures predictive of sinus bacteriology in cystic fibrosis? Pediatr Pulmonol (2006) 0.94
Massive hemoptysis in cystic fibrosis. Chest (2005) 0.93
Factor viia for alveolar hemorrhage in microscopic polyangiitis. Am J Respir Crit Care Med (2002) 0.93
Primary ciliary dyskinesia in Amish communities. J Pediatr (2010) 0.92
Transforming growth factor-beta(1) in bronchoalveolar lavage fluid from children with cystic fibrosis. Pediatr Pulmonol (2009) 0.92
Bronchoscopy-derived correlates of lung injury following inhalational injuries: a prospective observational study. PLoS One (2013) 0.89
Founder mutation in RSPH4A identified in patients of Hispanic descent with primary ciliary dyskinesia. Hum Mutat (2013) 0.89
Live attenuated influenza virus (LAIV) induces different mucosal T cell function in nonsmokers and smokers. Clin Immunol (2012) 0.89
Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients. J Cyst Fibros (2005) 0.88
Age of Pseudomonas aeruginosa acquisition and subsequent severity of cystic fibrosis lung disease. Pediatr Pulmonol (2010) 0.87
Sulforaphane induces SLPI secretion in the nasal mucosa. Respir Med (2012) 0.84
Airway retention of materials of different solubility following local intrabronchial deposition in dogs. J Aerosol Med (2003) 0.83
Release of cytokines by human nasal epithelial cells and peripheral blood mononuclear cells infected with Mycoplasma pneumoniae. Exp Biol Med (Maywood) (2002) 0.83
Inhaled versus systemic antibiotics and airway inflammation in children with cystic fibrosis and Pseudomonas. Pediatr Pulmonol (2010) 0.83
Diesel exhaust particles modify natural killer cell function and cytokine release. Part Fibre Toxicol (2013) 0.81
DNA and inflammatory mediators in bronchoalveolar lavage fluid from children with acute inhalational injuries. J Burn Care Res (2013) 0.81
Caregiver perspectives on discussions about the use of intensive treatments in cystic fibrosis. J Pain Symptom Manage (2010) 0.81
Cutting edge genetic studies in primary ciliary dyskinesia. Thorax (2012) 0.80
Mutations in DNAI1 (IC78) cause primary ciliary dyskinesia. Chest (2002) 0.80
Caregivers' perspectives on decision making about lung transplantation in cystic fibrosis. Prog Transplant (2009) 0.78
Primary ciliary dyskinesia-causing mutations in Amish and Mennonite communities. J Pediatr (2013) 0.77
A new tool improves diagnostic test performance for transmission em evaluation of axonemal dynein arms. Ultrastruct Pathol (2013) 0.77
Persistent Left Superior Vena Cava Identified During Central Line Placement: A Case Report. Respir Med CME (2011) 0.76
Response. Chest (2014) 0.75
The international primary ciliary dyskinesia cohort (iPCD Cohort): methods and first results. Eur Respir J (2017) 0.75
Family caregiver perspectives on symptoms and treatments for patients dying from complications of cystic fibrosis. J Pain Symptom Manage (2010) 0.75
Sleep-disordered breathing in Beckwith-Wiedemann syndrome: three patients. Am J Med Genet A (2012) 0.75
Official American Thoracic Society Clinical Practice Guidelines: Diagnostic Evaluation of Infants with Recurrent or Persistent Wheezing. Am J Respir Crit Care Med (2016) 0.75
Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease. Vaccine (2012) 0.75